The Official Journal of EuroPCR and the European Association of Percutaneous Coronary Interventions (EAPCI)


Intravenous enoxaparin anticoagulation in percutaneous left atrial cardiac procedures

EuroIntervention 2017;13:1226-1233 published online August 2017. DOI: 10.4244/EIJ-D-17-00518

1. Sorbonne Université Paris 6, ACTION study group, Institut de Cardiologie (AP-HP), INSERM UMRS 1166, Institute of Cardiometabolism and Nutrition (ICAN), Paris, France; 2. Emergency and Critical Care Center, Beijing Anzhen Hospital, Capital Medical Unive

Aims: Percutaneous transcatheter device closure of left atrial appendage (LAA), patent foramen ovale (PFO) and atrial septal defect (ASD) are usually performed with unfractionated heparin

Sign in to read and download the full article

Forgot your password?
No account yet? Sign up for free!
Create my pcr account

Join us for free and access thousands of articles from EuroIntervention, as well as presentations, videos, cases from

Read next article
3D printing for sizing left atrial appendage closure device: head-to-head comparison with computed tomography and transoesophageal echocardiography